Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05296473 · ClinicalTrials.gov registry record · NA
Guided ADHD Therapy for Managing the Extent and Severity of Symptoms
A NA study of ADHD, sponsored by Lumos Labs.
- Completed
- Registry status
- NA
- Development phase
- 560
- Enrollment target
- 13
- Study locations
NCT05296473: Completed NA study of ADHD, sponsored by Lumos Labs.
NCT05296473 is a NA study of ADHD that has completed, run by Lumos Labs. The registered enrollment target is 560 participants, above the 183-participant average among 75 other ADHD trials with a reported enrollment target (206% higher). The trial reports 13 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05296473, a NA study of ADHD, has completed, sponsored by Lumos Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 560 participants
- Enrollment target
- 13
- Study locations
Study Summary
The objective of this study is to assess the safety and effectiveness of an at-home, game-based digital therapy for treating adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD).
Primary Outcome
The TOVA is a standardized, computerized, continuous performance test (CPT). The TOVA Attention Comparison Score (ACS) is a comparison of a subject's scores to scores from a normative ADHD population. A score of \< 0 indicates a subject's performance is similar to that of the normative ADHD population, with a lower score indicating a more severe ADHD profile. A positive change on the TOVA ACS from Day 0 to Day 63 indicates improvement.
Conditions Studied
Interventions
- DEVICE ADHD Therapy
- DEVICE Control Therapy
Study Locations (13)
California
- CNS Network - Garden Grove
- University of California Davis MIND Institute - Sacramento
- University of California San Francisco - San Francisco
North Carolina
- Duke University - Durham
- Mindpath Care Centers - Raleigh
Arizona
- Melmed Center - Scottsdale
Florida
- Accel Research Sites - Maitland Clinical Research Unit - Maitland
Missouri
- Midwest Research Group - Saint Charles
Nebraska
- Alivation Research, LLC - Lincoln
Nevada
- Center of Psychiatry and Behavioral Medicine - Las Vegas
New Jersey
- Center for Emotional Fitness - Cherry Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 560 participants |
| Start Date | 2022-05-05 |
| Est. Completion | 2024-03-12 |
| Phase | NA |
What the finished NCT05296473 record still lists
NCT05296473 is an interventional study that assigns participants to a tested intervention. The registered 560 participants enrollment target is mid-sized for trials with a published cap, above the 183-participant average among 75 other ADHD trials with a reported enrollment target (206% higher).
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which ADHD Therapy is the first listed.
NCT05296473 lists 13 locations in 10 states (California, North Carolina, Arizona).
Frequently Asked Questions
What is clinical trial NCT05296473 about?
NCT05296473 is a clinical study titled "Guided ADHD Therapy for Managing the Extent and Severity of Symptoms". The objective of this study is to assess the safety and effectiveness of an at-home, game-based digital therapy for treating adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD).
What is the current status of trial NCT05296473?
This trial is currently completed. It is a NA study. The enrollment target is 560 participants. The study started on 2022-05-05. Estimated completion is 2024-03-12.
What conditions does trial NCT05296473 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT05296473?
The interventions under investigation include: ADHD Therapy (DEVICE), Control Therapy (DEVICE).
Who is sponsoring clinical trial NCT05296473?
This trial is sponsored by Lumos Labs, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05296473 being conducted?
This trial has 13 study locations across Arizona, California, Florida, Missouri, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05296473's enrollment target sits among peer trials
560 3rd of 75 higher than 73 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
-
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
RECRUITING · NA
-
A Pilot Study of a Remote ADHD Monitoring Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
- NCT06001541 · 560 participants · NA
Web-based Program to Improve Self-management Among Veterans-caregiver Dyads
- NCT06246916 · 560 participants · Phase 3
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI